China currently reports an research & development by business enterprise, pharmaceutical industry in current ppp $ of 23,635.32 million, which represents an increase of 4,092.00 million (20.9%) from 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in China
No matching regions
Similar regions to China
Business R&D pharmaceutical in current PPP $
China Business R&D pharmaceutical in current PPP $ between 2000 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 23,635.32M | +4,092.00M |
| 2020 | 19,543.32M | +4,528.07M |
| 2019 | 15,015.25M | +826.85M |
| 2018 | 14,188.40M | +966.37M |
| 2017 | 13,222.03M | +614.01M |
| 2016 | 12,608.02M | +933.93M |
| 2015 | 11,674.09M | +1,107.04M |
| 2014 | 10,567.06M | +966.48M |
| 2013 | 9,600.57M | +1,598.22M |
| 2012 | 8,002.35M | +2,008.65M |
| 2011 | 5,993.71M | +988.89M |
| 2010 | 5,004.81M | +736.38M |
| 2009 | 4,268.43M | +1,032.20M |
| 2008 | 3,236.23M | +2,374.44M |
| 2000 | 861.79M |